Topic: Co-morbidities - Page 3 - Central Africa IeDEA

Whole-genome sequencing for drug resistance profile prediction in mycobacterium tuberculosis

April 2019 | Antimicrobial Agents and Chemotherapy

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

February 2019 | Lancet Infectious Diseases

Trends in hepatitis B virus testing practices and management in HIV clinics across sub-Saharan Africa

November 2017 | BMC Infectious Diseases

Tuberculosis treatment outcomes among HIV/TB-coinfected children in the International epidemiology Databases to Evaluate AIDS (IeDEA) network

June 2017 | Journal of Acquired Immune Deficiency Syndromes

Depression, retention in care, and uptake of PMTCT service in Kinshasa, the Democratic Republic of Congo: a prospective cohort

May 2017 | AIDS Care: Psychological and Socio-medical Aspects of AIDS/HIV

Low implementation of Xpert MTB/RIF among HIV/TB co-infected adults in the International epidemiologic Databases to Evaluate AIDS (IeDEA) program

February 2017 | PLoS One

Bone quality assessed using quantitative ultrasound at the distal radius does not differ in antiretroviral therapy-naïve HIV-positive and HIV-negative Rwandan women

November 2016 | HIV Medicine

Impact of WHO 2010 guidelines on antiretroviral therapy initiation among patients with HIV-associated tuberculosis in clinics with and without onsite HIV services in the Democratic Republic of Congo

August 2016 | Tuberculosis Research and Treatment

Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control (“Three I’s”) and HIV-Tuberculosis Service Integration in Lower Income Countries

April 2016 | PLoS One

Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi’s sarcoma in five countries across sub-Saharan Africa

February 2016 | BMC Cancer